BRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into Equity

Reuters12-17

Dec 17 (Reuters) - Evaxion Biotech A/S EVAX.O:

EVAXION PURSUES AGREEMENT WITH EIB TO BOLSTER EQUITY THROUGH CONVERSION OF DEBT INTO EQUITY
EVAXION BIOTECH A/S - IN ADVANCED DISCUSSIONS WITH EIB FOR €3.5 MILLION LOAN CONVERSION

Source text: ID:nGNX7LtMsW

Further company coverage: EVAX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492950299?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-17 22:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492950299","market":"us","top_or_hot":-1,"title":"BRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into Equity","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into Equity</title></head><body><p><span>Dec 17 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/EVAX\">Evaxion Biotech A/S</a> <span>EVAX.O</span>:</p><ul><li><p>EVAXION PURSUES AGREEMENT WITH EIB TO BOLSTER EQUITY THROUGH CONVERSION OF DEBT INTO EQUITY</p></li><li><p>EVAXION BIOTECH A/S - IN ADVANCED DISCUSSIONS WITH EIB FOR €3.5 MILLION LOAN CONVERSION</p></li></ul><p>Source text: <span>ID:nGNX7LtMsW</span></p><p>Further company coverage: <span>EVAX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into Equity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into Equity\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 22:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUACB7VYH:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into EquityDec 17 (Reuters) - Evaxion Biotech A/S EVAX.O:EVAXION PURSUES AGREEMENT WITH EIB TO BOLSTER EQUITY ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUACB7VYH:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EVAX","symbol_name":"Evaxion Biotech A/S","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUACB7VYH:1","article_id":"2492950299","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492950299","pubTimestamp":1734444424,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into EquityDec 17 (Reuters) - Evaxion Biotech A/S EVAX.O:EVAXION PURSUES AGREEMENT WITH EIB TO BOLSTER EQUITY THRO","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EVAX":"Evaxion Biotech A/S","BK4139":"生物科技"},"translate_title":"简介-Evaxion寻求与EIB达成协议，通过债转股来增强股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVAX":0.9},"content_text":"BRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into EquityDec 17 (Reuters) - Evaxion Biotech A/S EVAX.O:EVAXION PURSUES AGREEMENT WITH EIB TO BOLSTER EQUITY THROUGH CONVERSION OF DEBT INTO EQUITYEVAXION BIOTECH A/S - IN ADVANCED DISCUSSIONS WITH EIB FOR €3.5 MILLION LOAN CONVERSIONSource text: ID:nGNX7LtMsWFurther company coverage: EVAX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492950299"}